Affiliation:
1. Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York.
Abstract
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and >3 000 000 patients worldwide as of April 28, 2020. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2, which invades cells through the angiotensin-converting enzyme 2 receptor. Among patients with COVID-19, there is a high prevalence of cardiovascular disease, and >7% of patients experience myocardial injury from the infection (22% of critically ill patients). Although angiotensin-converting enzyme 2 serves as the portal for infection, the role of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers requires further investigation. COVID-19 poses a challenge for heart transplantation, affecting donor selection, immunosuppression, and posttransplant management. There are a number of promising therapies under active investigation to treat and prevent COVID-19.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference68 articles.
1. An interactive web-based dashboard to track COVID-19 in real time [published online February 19, 2020].;Dong E;Lancet Infect Dis
2. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)
3. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
4. The proximal origin of SARS-CoV-2 [published online March 17, 2020].;Andersen KG;Nat Med
5. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak [published online March 13, 2020].;Zhang T;Curr Biol
Cited by
1345 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献